Company / Operating Margin
Vistagen Therapeutics, Inc. Operating Margin History
FY2011-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-4308.3%
FY2023
5-year range
-5066.1% / -819.9%
FY2019-FY2023
Trend
+15.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 6 years, ranging from -5066.1% in FY2022 to -317.0% in FY2011.
Based on SEC 10-K filings.
-4308.3% in FY2023 with a 5-year CAGR of -3488.4%.
Declined from -819.9% to -4308.3% over the past 5 years.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -3488.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, operating margin increased 15.0% year-over-year.
- Peak operating margin was recorded in FY2011.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -4308.3% | +15.0% |
| FY2022 | -5066.1% | - |
| FY2021 | - | - |
| FY2018 | -819.9% | - |
| FY2017 | - | - |
| FY2014 | -3389.8% | -403.1% |
| FY2012 | -673.8% | -112.6% |
| FY2011 | -317.0% | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026